首页> 外国专利> TUMOUR-TARGETED NANOCAPSULE, PREPARATION METHOD THEREFOR AND USE THEREOF

TUMOUR-TARGETED NANOCAPSULE, PREPARATION METHOD THEREFOR AND USE THEREOF

机译:肿瘤靶向纳米胶囊,制备方法及其用途

摘要

Disclosed is a tumour-targeted nanocapsule comprising a polymer sensitive to a tumour microenvironment, a substance having an anti-tumour activity and encapsulated by the polymer, and a tumour diagnostic reagent or a contrast agent; wherein the polymer sensitive to the tumour microenvironment comprises a cross-linking agent sensitive to the tumour microenvironment and 2-methacryloyloxyethyl phosphorylcholine, and the cross-linking agent sensitive to the tumour microenvironment at least comprises a polypeptide cross-linking agent capable of being degraded by an enzyme overexpressed in the tumour microenvironment. The polypeptide cross-linking agent capable of being degraded by an enzyme overexpressed in the tumour microenvironment is preferably one or more of a polypeptide cross-linking agent capable of being degraded by matrix metalloproteinases and a polypeptide cross-linking agent capable of being degraded by hyaluronidases, and is more preferably one or more of a polypeptide cross-linking agent capable of being degraded by matrix metalloproteinases.
机译:本发明公开了一种肿瘤靶向纳米胶囊,其包括对肿瘤微环境敏感的聚合物,具有抗肿瘤活性并被该聚合物包封的物质以及肿瘤诊断试剂或造影剂。其中,对肿瘤微环境敏感的聚合物包括对肿瘤微环境敏感的交联剂和2-甲基丙烯酰氧基乙基磷酰胆碱,并且对肿瘤微环境敏感的交联剂至少包括能够被降解的多肽交联剂。在肿瘤微环境中过表达的酶。能够被在肿瘤微环境中过度表达的酶降解的多肽交联剂优选为能够被基质金属蛋白酶降解的多肽交联剂和能够被透明质酸酶降解的多肽交联剂中的一种或多种。 ,并且更优选是一种或多种能够被基质金属蛋白酶降解的多肽交联剂。

著录项

  • 公开/公告号WO2018228464A1

    专利类型

  • 公开/公告日2018-12-20

    原文格式PDF

  • 申请/专利权人 TIANJIN NANUO BIO-TECHNOLOGY CO LT;

    申请/专利号WO2018CN91218

  • 发明设计人 YUAN XUBO;KANG CHUNSHENG;LU YUNFENG;

    申请日2018-06-14

  • 分类号A61K9/51;A61K47/32;A61K39/395;A61P35;

  • 国家 WO

  • 入库时间 2022-08-21 11:57:45

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号